Oncology

Vaccine vial and syringe
#Cancer research #Cancer vaccine #DDW Turning Science into Business Summit #Events #Immunology / Virology & Vaccines #Oncology #Webinar

DDW Cancer Research Summit: Insight on cancer vaccines

The DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’ will take place online on 16 November at 7AM PST / 10AM EST / 3PM GMT / 4PM CET. This free summit, sponsored by Taconic Biosciences, will offer expert thought leadership… Read More

#Cancer Research #News

#Cancer research #DDW Turning Science into Business Summit #Drug discovery #Oncology

New DDW Highlights podcast: 23 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  To celebrate DDW’s first Turning Science into Business Summit on ‘Cancer research… Read More

#News

#Cancer research #DDW Turning Science into Business Summit #Drug discovery #Oncology

This week in drug discovery (16-20 October)  

News round-up for 16-20 October by DDW Digital Content Editor Diana Spencer. To celebrate DDW’s first Turning Science into Business Summit on ‘Cancer research opportunities and advances’, the news round-up this week highlights the latest developments in oncology drug discovery. The top stories:… Read More

#News

#Clinical trials #Deep learning #Immunotherapy #Oncology #Start-ups

New podcast: Drug discovery success stories

This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Global pharma start-up success stories”, and “Excitement at rectal… Read More

#News

Saline intravenous (iv) drip in a child's hand
#Charles River #Human disease models #Oncology #Paediatrics #Preclinical investigations

Paediatric models for preclinical testing of oncology drugs

The US Food and Drug Administration’s (FDA) Research to Accelerate Cures and Equity (RACE) for Children Act now requires all oncology drugs to be tested for paediatric indications ahead of approval. The EU regulation of the European Medicines Agency (EMA) is also being adapted to mirror… Read More

#Cancer Research #News

Prostate cancer cells
#Drug resistance #Oncology #Prostate cancer #The Institute of Cancer Research #The Institute of Oncology Research #The Royal Marsden NHS Foundation Trust

Researchers reverse prostate cancer drug resistance

Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature. In an early clinical trial, researchers showed that blocking the messages cancer uses to hijack white blood… Read More

#Cancer Research #News #Trending News

CAR-T therapy
#Cancer research #CAR-T #CARsgen Therapeutics #China #Oncology #Solid tumours

CAR T therapy successfully treats solid tumours in China

CARsgen has published evidence of over seven years of disease-free survival in advanced hepatocellular carcinoma (HCC) following treatment with its CAR-GPC3 T cell therapy. Hepatocellular carcinoma is one of the most common malignant tumours, with approximately 780,000 annual incidence cases globally. Recurrence and metastasis are common. Read More

#Cancer Research #Editor's Choice #News

Lung cancer
#FDA #Non-small cell lung cancer (NSCLC) #Oncology #Orphan drugs #Pfizer

Orphan designated precision drug approved in US for NSCLC

The US Food and Drug Administration (FDA) has approved orphan drug encorafenib (Braftovi) with binimetinib (Mektovi) for adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. The FDA also approved the FoundationOne CDx (tissue) and FoundationOne Liquid CDx (plasma) as companion… Read More

#News #Regulatory

Cancer research
#Cancer research #DDW Turning Science into Business Summit #Oncology #Webinar

DDW Cancer Research Summit: Strategies to get to market faster

The DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’ will feature experts and thought leaders in cancer research, precision medicine and immunotherapy. Andreas Dreps DDW is delighted to confirm that ICON’s SrVP and Global Head of Science Andreas Dreps and… Read More

#Cancer Research #News

Gastric cancer
#Antibody #FDA #Gastrointestinal #Oncology #Phase III trial #Stomach cancer #Transcenta

Antibody for gastric cancer progresses to Phase III trials

The US Food and Drug Administration (FDA) has granted clearance to Transcenta to proceed with its TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) for gastric cancer. The trial will investigate the drug in combination with Nivolumab and chemotherapy as a first-line treatment in… Read More

#Cancer Research #News #Regulatory

Cancer cell
#Cancer research #DDW Turning Science into Business Summit #Events #Oncology #Webinar

DDW Cancer Research Summit: Industry experts join the panel

The DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’ will feature an expert panel discussion on new drug discovery and development concepts and tools in cancer research. The free two-hour Summit, hosted by DDW, will take place online on 16… Read More

#News

IgG1 monoclonal antibody
#Artificial intelligence (AI) #Aulos Bioscience #Monoclonal antibodies #Oncology #Phase I trial #Solid tumours

Data supports IgG1 monoclonal antibody for solid tumours

Aulos Bioscience has revealed new safety and efficacy data from the Phase I dose escalation portion of its Phase I/II clinical trial of AU-007 in patients with unresectable locally advanced or metastatic solid tumour cancers. The data will be presented at the Society for Immunotherapy of… Read More

#Cancer Research #News

Non-small cell lung cancer
#Gene therapy #Lung cancer #Non-small cell lung cancer (NSCLC) #Oncology #Phase I trial

Non-viral gene therapy shows early efficacy in lung cancer

Positive Phase I trial data indicates that Reqorsa (quaratusugene ozeplasmid) has shown early efficacy for the treatment of non-small cell lung cancer (NSCLC). The data will be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. Developed by… Read More

#Cancer Research #News

Cancer research
#Cancer drug targets #Cancer research #DDW Turning Science into Business Summit #Drug discovery #Events #Immunotherapy #Oncology

DDW announces Summit on advances in cancer research

Join DDW’s Megan Thomas and Reece Armstrong with sponsor Taconic Biosciences for the first DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’, on 16 November at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. This free 2-hour… Read More

#Cancer Research #News

Cancer research
#Cancer research #DDW Turning Science into Business Summit #Drug discovery #Oncology #Taconic #Webinar

DDW Turning Science Into Business Summit: Cancer research opportunities and advances

Join DDW for its Turning Science into Business Summit: Cancer research opportunities and advances. This free online event will be hosted by DDW and is sponsored by Taconic Biosciences. The 2-hour Summit will outline areas of advancement and opportunity in the cancer research market and will consist of presentations from… Read More

Webinar date:
Sponsored by Taconic Biosciences
#Webinars